Open Access
Open access
Wiley
Cancer Communications
,  volume 45 ,  issue 4 ,  pages 460-464

Targeting ferroptosis resistance resensitizes metastatic HR+HER2− breast cancer cells to palbociclib‐hormone therapy

Charles Pottier 1, 2
, 
Laetitia Montero‐Ruiz 1, 3
, 
Robin Jehay 1
, 
Coline Wery 1
, 
Dominique Baiwir 4
, 
Gabriel Mazzucchelli 4
, 
Sophie Bekisz 5
, 
Romain Thissen 6
, 
Claire JOSSE 6
, 
Andrée Rorive 2
, 
Stéphanie GOFFLOT 7
, 
Ahmed Dahmani 8
, 
Ludivine Morisset 8
, 
Joëlle Collignon 2
, 
Philipe Delvenne 9
, 
Elisabetta Marangoni 8
, 
Agnès Noël 3
, 
Guy Jerusalem 2
, 
Nor Eddine Sounni 1
1
 
2
 
Medical Oncology Department University Hospital of Liège Liège Belgium | 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
Anatomie et cytologie pathologiques, University Hospital of Liège Liège Belgium | 
Publication type: Journal Article
Publication date: 2025-01-13
Wiley
scimago Q1
wos Q1
SJR: 6.403
CiteScore: 36.5
Impact factor: 24.9
ISSN: 25233548, 09553541
Found 
Found 

Top-30

Journals

1
Cancers
Cancers, 1, 20%
Cancers
1 publication, 20%
Antioxidants
Antioxidants, 1, 20%
Antioxidants
1 publication, 20%
Biomolecules
Biomolecules, 1, 20%
Biomolecules
1 publication, 20%
Cell Reports
Cell Reports, 1, 20%
Cell Reports
1 publication, 20%
ACS Applied Bio Materials
ACS Applied Bio Materials, 1, 20%
ACS Applied Bio Materials
1 publication, 20%
1

Publishers

1
2
3
MDPI
MDPI, 3, 60%
MDPI
3 publications, 60%
Elsevier
Elsevier, 1, 20%
Elsevier
1 publication, 20%
American Chemical Society (ACS)
American Chemical Society (ACS), 1, 20%
American Chemical Society (ACS)
1 publication, 20%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
5
Share
Cite this
GOST |
Cite this
GOST Copy
Pottier C. et al. Targeting ferroptosis resistance resensitizes metastatic HR+HER2− breast cancer cells to palbociclib‐hormone therapy // Cancer Communications. 2025. Vol. 45. No. 4. pp. 460-464.
GOST all authors (up to 50) Copy
Pottier C., Montero‐Ruiz L., Jehay R., Wery C., Baiwir D., Mazzucchelli G., Bekisz S., Thissen R., JOSSE C., Rorive A., GOFFLOT S., Dahmani A., Morisset L., Collignon J., Delvenne P., Marangoni E., Noël A., Jerusalem G., Sounni N. E. Targeting ferroptosis resistance resensitizes metastatic HR+HER2− breast cancer cells to palbociclib‐hormone therapy // Cancer Communications. 2025. Vol. 45. No. 4. pp. 460-464.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/cac2.12646
UR - https://onlinelibrary.wiley.com/doi/10.1002/cac2.12646
TI - Targeting ferroptosis resistance resensitizes metastatic HR+HER2− breast cancer cells to palbociclib‐hormone therapy
T2 - Cancer Communications
AU - Pottier, Charles
AU - Montero‐Ruiz, Laetitia
AU - Jehay, Robin
AU - Wery, Coline
AU - Baiwir, Dominique
AU - Mazzucchelli, Gabriel
AU - Bekisz, Sophie
AU - Thissen, Romain
AU - JOSSE, Claire
AU - Rorive, Andrée
AU - GOFFLOT, Stéphanie
AU - Dahmani, Ahmed
AU - Morisset, Ludivine
AU - Collignon, Joëlle
AU - Delvenne, Philipe
AU - Marangoni, Elisabetta
AU - Noël, Agnès
AU - Jerusalem, Guy
AU - Sounni, Nor Eddine
PY - 2025
DA - 2025/01/13
PB - Wiley
SP - 460-464
IS - 4
VL - 45
SN - 2523-3548
SN - 0955-3541
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Pottier,
author = {Charles Pottier and Laetitia Montero‐Ruiz and Robin Jehay and Coline Wery and Dominique Baiwir and Gabriel Mazzucchelli and Sophie Bekisz and Romain Thissen and Claire JOSSE and Andrée Rorive and Stéphanie GOFFLOT and Ahmed Dahmani and Ludivine Morisset and Joëlle Collignon and Philipe Delvenne and Elisabetta Marangoni and Agnès Noël and Guy Jerusalem and Nor Eddine Sounni},
title = {Targeting ferroptosis resistance resensitizes metastatic HR+HER2− breast cancer cells to palbociclib‐hormone therapy},
journal = {Cancer Communications},
year = {2025},
volume = {45},
publisher = {Wiley},
month = {jan},
url = {https://onlinelibrary.wiley.com/doi/10.1002/cac2.12646},
number = {4},
pages = {460--464},
doi = {10.1002/cac2.12646}
}
MLA
Cite this
MLA Copy
Pottier, Charles, et al. “Targeting ferroptosis resistance resensitizes metastatic HR+HER2− breast cancer cells to palbociclib‐hormone therapy.” Cancer Communications, vol. 45, no. 4, Jan. 2025, pp. 460-464. https://onlinelibrary.wiley.com/doi/10.1002/cac2.12646.